Thomas Hess

Nittany Lion Fund LLC is a private equity fund. The private company is based in University Park, PA.

Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA.

Keane is the number one provider of unclaimed property communications, compliance and consulting services in the country. From customized communications programs and data analysis to in-depth consulting and annual compliance reporting, Keane provides corporations, mutual funds, banks, brokerages, and transfer agents with a depth and breadth of services that is unmatched. Each Keane service helps clients reduce costs, protect shareholders, or retain customers while successfully navigating the complexities of unclaimed property regulations. What sets Keane apart is its commitment to customer service, the expertise of their employees, and its accountability for measurable results. Keane employs more than 160 people across the country, in New York, NY headquarters, the company's Wayne, PA operating facility and offices in Salt Lake City, UT and Sacramento County, CA.

Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.

Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA.